Evidence map›Paper›PMID 35645814›Full record

ArticleFrontiers in pharmacology2022

Potential Treat-to-Target Approach for Methamphetamine Use Disorder: A Pilot Study of Adenosine 2A Receptor Antagonist With Positron Emission Tomography.

Kyoji Okita, Toshihiko Matsumoto, Daisuke Funada, Maki Murakami, Koichi Kato, Yoko Shigemoto, Noriko Sato, Hiroshi Matsuda

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 71% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kyoji OkitaDepartment of Psychiatry, Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
Toshihiko MatsumotoDepartment of Psychiatry, Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
Daisuke FunadaDepartment of Psychiatry, Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
Maki MurakamiDepartment of Psychiatry, Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
Koichi KatoIntegrative Brain Imaging Center, National Center of Neurology and Psychiatry, Tokyo, Japan.
Yoko ShigemotoDepartment of Radiology, Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
Noriko SatoDepartment of Radiology, Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
Hiroshi MatsudaDepartment of Radiology, Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
National Center of Neurology and Psychiatry · JPNational Institute of Mental Health · JPSouthern Tohoku General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

addictionadenosine 2A receptordopamine D2 receptorsmethamphetamineneuroinflammationpositron emission tomography

Identifiers

PMID35645814
PMCPMC9130733
OpenAlexW4280576136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.